Letter to the editor submitted in response to "the extinction of topical erythromycin therapy for acne vulgaris and concern for the future of topical clindamycin"

J Dermatolog Treat. 2018 Feb;29(1):105-106. doi: 10.1080/09546634.2017.1335852. Epub 2017 Jun 8.
No abstract available

Publication types

  • Letter